OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic modifications: Key players in cancer heterogeneity and drug resistance
Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.
Translational Oncology (2023) Vol. 39, pp. 101821-101821
Open Access | Times Cited: 46
Hana Q. Sadida, Alanoud Abdulla, Sara Al Marzooqi, et al.
Translational Oncology (2023) Vol. 39, pp. 101821-101821
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 25
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 25
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways
Raed Obaid Saleh, Mushtak T.S. Al-Ouqaili, Eyhab Ali, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 18
Raed Obaid Saleh, Mushtak T.S. Al-Ouqaili, Eyhab Ali, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 18
Beyond genetics: Exploring the role of epigenetic alterations in breast cancer
Kirti S. Prabhu, Hana Q. Sadida, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155174-155174
Open Access | Times Cited: 16
Kirti S. Prabhu, Hana Q. Sadida, Shilpa Kuttikrishnan, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155174-155174
Open Access | Times Cited: 16
Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access | Times Cited: 2
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access | Times Cited: 2
Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies
Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Rahul Maheshwari, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 967-990
Open Access | Times Cited: 14
Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Rahul Maheshwari, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 967-990
Open Access | Times Cited: 14
Assessment of Anticancer Properties of Thai Plants
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 122-164
Closed Access | Times Cited: 13
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 122-164
Closed Access | Times Cited: 13
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development
Whi‐An Kwon, Ho Kyung Seo, Geehyun Song, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 86-86
Open Access | Times Cited: 1
Whi‐An Kwon, Ho Kyung Seo, Geehyun Song, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 86-86
Open Access | Times Cited: 1
Precision medicine in gynecological cancer (Review)
Aikaterini Aravantinou‐Fatorou, Vasiliki Georgakopoulou, Meletios Α. Dimopoulos, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access | Times Cited: 1
Aikaterini Aravantinou‐Fatorou, Vasiliki Georgakopoulou, Meletios Α. Dimopoulos, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access | Times Cited: 1
HDAC3-Mediated Deacetylation of p21 Stabilizes Protein Levels and Promotes 5-FU Resistance in Colorectal Cancer Cells
Weilin Jin, J. Wang, Yang Feng, et al.
Advances in Cancer Biology - Metastasis (2025), pp. 100136-100136
Open Access | Times Cited: 1
Weilin Jin, J. Wang, Yang Feng, et al.
Advances in Cancer Biology - Metastasis (2025), pp. 100136-100136
Open Access | Times Cited: 1
Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases
Ambreen Zahoor, Rafia Khazer, Insha Mehraj, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
Ambreen Zahoor, Rafia Khazer, Insha Mehraj, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma
Can Bora Yildiz, Jian Du, K. Naga Mohan, et al.
Epigenomics (2025) Vol. 17, Iss. 2, pp. 125-140
Closed Access
Can Bora Yildiz, Jian Du, K. Naga Mohan, et al.
Epigenomics (2025) Vol. 17, Iss. 2, pp. 125-140
Closed Access
Epigenetic modulation by oncolytic viruses: Implications for cancer therapeutic efficacy
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
Muhammad Haris Sultan, Qi Zhang, Hao Jin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189270-189270
Closed Access
Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access
Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response prediction
Ning Wang, Yinan Li, Yaoyao Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ning Wang, Yinan Li, Yaoyao Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Extracellular vesicle-mediated chemoresistance in breast cancer: focus on miRNA cargo
Maria Chiara Ciferri, Roberta Tasso
Extracellular Vesicles and Circulating Nucleic Acids (2025) Vol. 6, Iss. 1, pp. 112-27
Open Access
Maria Chiara Ciferri, Roberta Tasso
Extracellular Vesicles and Circulating Nucleic Acids (2025) Vol. 6, Iss. 1, pp. 112-27
Open Access
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access
The Histomorphology to Molecular Transition: Exploring the Genomic Landscape of Poorly Differentiated Epithelial Endometrial Cancers
Thulo Molefi, Lloyd Mabonga, Rodney Hull, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 382-382
Open Access
Thulo Molefi, Lloyd Mabonga, Rodney Hull, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 382-382
Open Access
Paclitaxel Resistance in Breast Cancer: Current Challenges and Recent Advanced Therapeutic Strategies
Heidi A Abouzeid, Loay Kassem, Xumei Liu, et al.
Cancer Treatment and Research Communications (2025), pp. 100918-100918
Open Access
Heidi A Abouzeid, Loay Kassem, Xumei Liu, et al.
Cancer Treatment and Research Communications (2025), pp. 100918-100918
Open Access
Enhancing venetoclax efficacy in leukemia through association with HDAC inhibitors
Jorge Antonio Elias Godoy Carlos, Maurício T. Tavares, Keli Lima, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Jorge Antonio Elias Godoy Carlos, Maurício T. Tavares, Keli Lima, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
The Immunoradiotherapy in HNSCC
Tao Zhang, Wei Du, S.D. Zhang, et al.
(2025), pp. 53-107
Closed Access
Tao Zhang, Wei Du, S.D. Zhang, et al.
(2025), pp. 53-107
Closed Access
Reflections and perspectives on epigenetically mediated biological control: compromises in cancer and skeletal pathology
Gary S. Stein
Academia Biology (2025) Vol. 3, Iss. 2
Open Access
Gary S. Stein
Academia Biology (2025) Vol. 3, Iss. 2
Open Access
The importance of protein domain mutations in cancer therapy
Kiran Kumar Chitluri, Isaac Arnold Emerson
Heliyon (2024) Vol. 10, Iss. 6, pp. e27655-e27655
Open Access | Times Cited: 3
Kiran Kumar Chitluri, Isaac Arnold Emerson
Heliyon (2024) Vol. 10, Iss. 6, pp. e27655-e27655
Open Access | Times Cited: 3
Pharmacological agents targeting drug-tolerant persister cells in cancer
Yu‐Chi Chen, Krishne Gowda, Shantu Amin, et al.
Pharmacological Research (2024) Vol. 203, pp. 107163-107163
Open Access | Times Cited: 3
Yu‐Chi Chen, Krishne Gowda, Shantu Amin, et al.
Pharmacological Research (2024) Vol. 203, pp. 107163-107163
Open Access | Times Cited: 3
Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
